Cargando…

Erratum to: A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1

Detalles Bibliográficos
Autores principales:	Uemura, Marc, Fa’ak, Faisal, Haymaker, Cara, McQuail, Natalie, Sirmans, Elizabeth, Hudgens, Courtney W., Barbara, Lydia, Bernatchez, Chantale, Curry, Jonathan L., Hwu, Patrick, Tetzlaff, Michael T., Diab, Adi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244590/ https://www.ncbi.nlm.nih.gov/pubmed/28116090 http://dx.doi.org/10.1186/s40425-017-0208-7

Ejemplares similares

A case report of Grover’s disease from immunotherapy-a skin toxicity induced by inhibition of CTLA-4 but not PD-1
por: Uemura, Marc, et al.
Publicado: (2016)

Pilot study of intratumoral (IT) cryoablation (cryo) in combination with systemic checkpoint blockade in patients with metastatic melanoma (MM)
por: Kim, Dae Won, et al.
Publicado: (2015)

TIL therapy and anti-CTLA4: can they co-exist?
por: Forget, Marie-Andrée, et al.
Publicado: (2019)

Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn’s disease: a case report
por: Uemura, Marc, et al.
Publicado: (2016)

You can run but you can't hide: tracking T cells in metastatic melanoma patients treated with tumor-infiltrating lymphocytes
por: Haymaker, Cara, et al.
Publicado: (2015)

Preclinical development of tumor-infiltrating lymphocyte therapy for ovarian cancer
por: Sakellariou-Thompson, Donastas, et al.
Publicado: (2015)

Modification of BTLA signaling motifs in TIL exhibits positive signals that mediate anti-tumor control
por: Ritthipichai, Krit, et al.
Publicado: (2015)

PD-1 and BTLA and CD8(+) T-cell “exhaustion” in cancer: “Exercising” an alternative viewpoint
por: Haymaker, Cara, et al.
Publicado: (2012)

LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade
por: Hickman, Amber, et al.
Publicado: (2022)

Single-cell motility and gene expression signature as predictors of the overall survival of act in melanoma patients
por: Martinez-Paniagua, Melisa, et al.
Publicado: (2015)

Development of novel combinations of targeted and immunotherapies by understanding immune resistance using a high throughput assay of T cell mediated cytotoxicity
por: Malu, Shruti, et al.
Publicado: (2013)

Grover F. Powers. In memoriam.
por: Gordon, H. H.
Publicado: (1969)

Bibliography of Grover f. Powers
Publicado: (1952)

A Case Report of Atezolizumab Induced Tumor Lysis Syndrome
por: Fa’ak, Faisal, et al.
Publicado: (2019)

Identification of predictive biomarker signatures in melanoma tumors associated with response to tumor-infiltrating lymphocyte (TIL) therapy
por: Chen, Jie Qing, et al.
Publicado: (2013)

Uncovering a novel function of BTLA on tumor-infiltrating CD8+ T cells
por: Haymaker, Cara, et al.
Publicado: (2013)

Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy
por: Sharma, Meenu, et al.
Publicado: (2020)

The beneficial effects of a gas-permeable flask for expansion of Tumor-Infiltrating lymphocytes as reflected in their mitochondrial function and respiration capacity
por: Forget, Marie-Andrée, et al.
Publicado: (2015)

Grover Francis Powers and Pediatrics at Yale
por: Darrow, Daniel C.
Publicado: (1952)

Case for diagnosis. Atypical Grover’s disease()()
por: Vargas-Mora, Pablo, et al.
Publicado: (2021)

Grover disease associated with docetaxel chemotherapy
por: Afvari, Shawn, et al.
Publicado: (2022)

An Unusual Trigger of Grover’s Disease (GD)
por: Haniff, Shaniza, et al.
Publicado: (2023)

BTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival properties
por: Haymaker, Cara L, et al.
Publicado: (2015)

Intra-patient intra-tumoral immune heterogeneity is evident at progression on targeted therapy and immunotherapy for melanoma
por: Reuben, Alexandre, et al.
Publicado: (2014)

Immune-Modulation by Epidermal Growth Factor Receptor Inhibitors: Implication on Anti-Tumor Immunity in Lung Cancer
por: Im, Jin S., et al.
Publicado: (2016)

Grover's Disease in a Liver Transplant Patient
por: Moon, Hye-Rim, et al.
Publicado: (2014)

La acción de los medios : los medios de comunicación y el interés público /
por: McQuail, Denis
Publicado: (1998)

Audience analysis
por: McQuail, Denis
Publicado: (1997)

Media performance : mass communication and the public interest
por: McQuail, Denis
Publicado: (1992)

Mass communication theory : an introduction
por: McQuail, Denis
Publicado: (1994)

Sociología de los medios masivos de comunicación
por: McQuail, Denis
Publicado: (1972)

Introducción a la teoría de la comunicación de masas
por: McQuail, Denis
Publicado: (2000)

Introducción a la teoría de la comunicación de masas
por: McQuail, Denis

Erratum: “Evaluation of a Physiologically Based Pharmacokinetic (PBPK) Model for Inorganic Arsenic Exposure Using Data from Two Diverse Human Populations”
por: El-Masri, Hisham A., et al.
Publicado: (2018)

Erratum to: CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease
por: Pawlak-Adamska, Edyta, et al.
Publicado: (2017)

Basis for a neuronal version of Grover's quantum algorithm
por: Clark, Kevin B.
Publicado: (2014)

Difficulties in modelling ARDS (2017 Grover Conference Series)
por: Uhlig, Stefan, et al.
Publicado: (2018)

Quantifying computational advantage of Grover’s algorithm with the trace speed
por: Gebhart, Valentin, et al.
Publicado: (2021)

Autophagy-lysosome inhibitor chloroquine prevents CTLA-4 degradation of T cells and attenuates acute rejection in murine skin and heart transplantation: Erratum
por: Cui, Jikai, et al.
Publicado: (2022)

Lofty goals at high altitude: The Grover Conferences, 1984–2011
por: Weir, E. Kenneth, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_92jdlv3l4173su3h34e15etd97